Evaluation of NUN-004, a Novel Engineered Ephrin Antagonist, in Healthy Volunteers and Patients with Amyotrophic Lateral Sclerosis: A Phase I/Ib, Open-Label, Escalating Dose and Extended Access Study
肌萎缩侧索硬化
医学
敌手
打开标签
药理学
肿瘤科
内科学
受体
疾病
不利影响
作者
Michael Gerometta,Robert D. Henderson,Richard Friend,Leanne Cooper,Jing Zhao,Andy Boyd,Perry F. Bartlett